These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19394232)

  • 1. Studies on novel 2-imidazolidinones and tetrahydropyrimidin-2(1H)-ones as potential TACE inhibitors: design, synthesis, molecular modeling, and preliminary biological evaluation.
    DasGupta S; Murumkar PR; Giridhar R; Yadav MR
    Bioorg Med Chem; 2009 May; 17(10):3604-17. PubMed ID: 19394232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.
    Sengupta P; Puri CS; Chokshi HA; Sheth CK; Midha AS; Chitturi TR; Thennati R; Murumkar PR; Yadav MR
    Eur J Med Chem; 2011 Nov; 46(11):5549-55. PubMed ID: 21963348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.
    Zhang C; Lovering F; Behnke M; Zask A; Sandanayaka V; Sun L; Zhu Y; Xu W; Zhang Y; Levin JI
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3445-8. PubMed ID: 19464885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.
    Bandarage UK; Wang T; Come JH; Perola E; Wei Y; Rao BG
    Bioorg Med Chem Lett; 2008 Jan; 18(1):44-8. PubMed ID: 18054488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and activity relationships of tartrate-based TACE inhibitors.
    Li D; Popovici-Muller J; Belanger DB; Caldwell J; Dai C; David M; Girijavallabhan VM; Lavey BJ; Lee JF; Liu Z; Mazzola R; Rizvi R; Rosner KE; Shankar B; Spitler J; Ting PC; Vaccaro H; Yu W; Zhou G; Zhu Z; Niu X; Sun J; Guo Z; Orth P; Chen S; Kozlowski JA; Lundell DJ; Madison V; McKittrick B; Piwinski JJ; Shih NY; Shipps GW; Siddiqui MA; Strickland CO
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4812-5. PubMed ID: 20638281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular modeling analysis of novel non-hydroxamate inhibitors of TACE.
    Sheppeck JE; Tebben A; Gilmore JL; Yang A; Wasserman ZR; Decicco CP; Duan JJ
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1408-12. PubMed ID: 17188861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and immunosuppressive activity evaluation of substituted N-imidazolidin-2-ones and N-tetrahydropyrimidin-2(1H)-ones.
    Sabourin C; Robert JM
    J Enzyme Inhib Med Chem; 2008 Oct; 23(5):659-67. PubMed ID: 18821255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.
    Chun K; Park SK; Kim HM; Choi Y; Kim MH; Park CH; Joe BY; Chun TG; Choi HM; Lee HY; Hong SH; Kim MS; Nam KY; Han G
    Bioorg Med Chem; 2008 Jan; 16(1):530-5. PubMed ID: 17936631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.
    Gilmore JL; King BW; Harris C; Maduskuie T; Mercer SE; Liu RQ; Covington MB; Qian M; Ribadeneria MD; Vaddi K; Trzaskos JM; Newton RC; Decicco CP; Duan JJ
    Bioorg Med Chem Lett; 2006 May; 16(10):2699-704. PubMed ID: 16516466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors.
    Duan JJ; Chen L; Lu Z; Xue CB; Liu RQ; Covington MB; Qian M; Wasserman ZR; Vaddi K; Christ DD; Trzaskos JM; Newton RC; Decicco CP
    Bioorg Med Chem Lett; 2008 Jan; 18(1):241-6. PubMed ID: 18032037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.
    Chen XT; Ghavimi B; Corbett RL; Xue CB; Liu RQ; Covington MB; Qian M; Vaddi KG; Christ DD; Hartman KD; Ribadeneira MD; Trzaskos JM; Newton RC; Decicco CP; Duan JJ
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1865-70. PubMed ID: 17276676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.
    Rosner KE; Guo Z; Orth P; Shipps GW; Belanger DB; Chan TY; Curran PJ; Dai C; Deng Y; Girijavallabhan VM; Hong L; Lavey BJ; Lee JF; Li D; Liu Z; Popovici-Muller J; Ting PC; Vaccaro H; Wang L; Wang T; Yu W; Zhou G; Niu X; Sun J; Kozlowski JA; Lundell DJ; Madison V; McKittrick B; Piwinski JJ; Shih NY; Arshad Siddiqui M; Strickland CO
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1189-93. PubMed ID: 20022498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
    Duan JJ; Chen L; Lu Z; Jiang B; Asakawa N; Sheppeck JE; Liu RQ; Covington MB; Pitts W; Kim SH; Decicco CP
    Bioorg Med Chem Lett; 2007 Jan; 17(1):266-71. PubMed ID: 17027261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.
    Duan JJ; Chen L; Wasserman ZR; Lu Z; Liu RQ; Covington MB; Qian M; Hardman KD; Magolda RL; Newton RC; Christ DD; Wexler RR; Decicco CP
    J Med Chem; 2002 Nov; 45(23):4954-7. PubMed ID: 12408705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
    Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.
    Duan JJ; Lu Z; Wasserman ZR; Liu RQ; Covington MB; Decicco CP
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2970-3. PubMed ID: 15908214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
    Huang A; Joseph-McCarthy D; Lovering F; Sun L; Wang W; Xu W; Zhu Y; Cui J; Zhang Y; Levin JI
    Bioorg Med Chem; 2007 Sep; 15(18):6170-81. PubMed ID: 17606376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
    Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
    ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitors.
    Shiozaki M; Maeda K; Miura T; Ogoshi Y; Haas J; Fryer AM; Laird ER; Littmann NM; Andrews SW; Josey JA; Mimura T; Shinozaki Y; Yoshiuchi H; Inaba T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1575-80. PubMed ID: 19243944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.
    Lu Z; Ott GR; Anand R; Liu RQ; Covington MB; Vaddi K; Qian M; Newton RC; Christ DD; Trzaskos J; Duan JJ
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1958-62. PubMed ID: 18282708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.